Danimer scientific announces intention to complete a reverse stock split

Bainbridge, ga.--(business wire)--danimer scientific, inc. (nyse: dnmr) (“danimer” or “company”), a leading, next-generation biotechnology company focused on the production of biomaterials, announced today that, following approval by the company's stockholders and its board of directors, the company will effect a reverse stock split (“reverse stock split”) of danimer's class a common stock, par value $0.0001 per share (“common stock”), at a ratio of 1-for-40 (the “reverse stock split ratio”), w.
DNMR Ratings Summary
DNMR Quant Ranking